COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments

Since December 2019, the pandemic caused by coronavirus disease 2019 (COVID-19) raises a real public health problem. COVID-19 appeared in Wuhan (Hubei province) in China. Drugs that have been used in rheumatology for decades seem to be effective in this infection and are for the most part being stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouédraogo, Dieu-Donné, Tiendrébéogo, Wendlassida Joelle Stéphanie, Kaboré, Fulgence, Ntsiba, Honoré
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256179/
https://www.ncbi.nlm.nih.gov/pubmed/32472461
http://dx.doi.org/10.1007/s10067-020-05189-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256179/
https://www.ncbi.nlm.nih.gov/pubmed/32472461
http://dx.doi.org/10.1007/s10067-020-05189-y

Ejemplares similares